Sold as Indocin. Every FDA application for this active ingredient: 1 branded and 3 generic.
As of Nov 15, 2026, FDA lists 4 applications for Indomethacin Sodium (sold as Indocin), first approved Jan 30, 1985, with 0 new uses approved and 0 published complete response letters.
| Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator PlacementPain Management, Abortion · Rush University Medical Center | Phase 2 | Recruiting | Mar 23, 2026 |
| Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic DissectionAortic Dissection, Inflammation · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 3 | Recruiting | May 13, 2025 |
| Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal SkinRectal Cancer, Radiotherapy, Anal Pain · Qianfoshan Hospital | Not applicable | Recruiting | Feb 20, 2025 |
| Ketorolac Intravenous Regional Analgesia in Lower Limb SurgeriesPostoperative Pain, Acute · Mansoura University | Not applicable | Recruiting | Sep 16, 2022 |
| Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau FracturesTibial Plateau Fractures · University of Utah | Early phase 1 | Active, not recruiting | Sep 8, 2021 |
| Treatment of Orthostatic IntoleranceTachycardia, Chronic Orthostatic Intolerance · Satish R. Raj | Phase 1 / Phase 2 | Active, not recruiting | Dec 6, 2005 |
| Jan 30, 1985 | IndocinNDA 18878 · New dosage form | Recordati Rare | 17 | Discontinued |
| Jul 16, 2008 | Indomethacin SodiumANDA 78713 | Hikma | 0 | Discontinued |
| Apr 19, 2016 | Indomethacin SodiumANDA 204118 | Hospira | 1 | Discontinued |
| Jul 19, 2017 | Indomethacin SodiumANDA 206561 | Navinta LLC | 1 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA